This public education campaign was created to give the millions of sinus sufferers around the world access to patient focused, trusted information about their sinus symptoms and conditions, and to differentiate smell loss related to colds, allergies, sinus issues, and COVID-19.
An acute loss of smell is one of the most common symptoms of COVID-19, but for two decades it has been linked to other maladies among them Parkinson’s disease and dementia. Now, a poor sense of smell may signify a higher risk of pneumonia in older adults, says a team of Michigan State University researchers.
A Monell Chemical Senses Center and Temple University team recently became part of a new, multi-institute National Institute of Health (NIH)-funded initiative called the Rapid Acceleration of Diagnostic Radical program (RADx). The NIH invested $107 million at 43 institutions across the country to support non-traditional and repurposed technologies to combat the pandemic and address future viral disease outbreaks.
Do I have COVID-19 or is it something else? Bobby Tajudeen, MD, director of rhinology, sinus surgery and skull base surgery at Rush University Medical Center explains the differences between common smell loss and smell loss as a COVID-19 symptom and when to see a specialist.
Studies that used direct measures versus self-report of smell loss could explain the a wide range of estimates – studies using direct measures, about 77% of COVID-19 patients had smell loss versus only 44% with self-report.
Direct measures of smell ability involve having patients smell and report on actual odorants, whereas self-report methods include obtaining data through patient questionnaires, interviews, or electronic health records. Direct measures are objective whereas self-report are subjective measures of a person’s experience.